Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model

This publication has 29 references indexed in Scilit:

• The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals
  Infection Control & Hospital Epidemiology, 2001
• Linezolid
  Drugs, 2001
• Bacteremic Pneumonia Due to Staphylococcus aureus: A Comparison of Disease Caused by Methicillin-Resistant and Methicillin-Susceptible Organisms
  Clinical Infectious Diseases, 1999
• Discussion
  International Journal of Antimicrobial Agents, 1999
• Nosocomial Methicillin-Resistant and Methicillin-SusceptibleStaphylococcus AureusPrimary Bacteremia: At What Costs?
  Infection Control & Hospital Epidemiology, 1999
• Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
  Diagnostic Microbiology and Infectious Disease, 1999
• A Randomised Comparative Study of Once-Daily Ceftriaxone and 6-Hourly Flucloxacillin in the Treatment of Moderate to Severe Cellulitis
  Clinical Drug Investigation, 1996
• An analysis of 900 consecutive admissions to a regional infection unit
  Journal of Infection, 1994
• Economic Evaluation of Lenograstim for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer
  PharmacoEconomics, 1994
• The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults
  Archives of internal medicine (1960), 1990